| Year |
Citation |
Score |
| 2021 |
Ray AT, Mazot P, Brewer JR, Catela C, Dinsmore CJ, Soriano P. Corrigendum: FGF signaling regulates development by processes beyond canonical pathways. Genes & Development. 35: 783. PMID 33941542 DOI: 10.1101/gad.348503.121 |
0.689 |
|
| 2020 |
Ray AT, Mazot P, Brewer JR, Catela C, Dinsmore CJ, Soriano P. FGF signaling regulates development by processes beyond canonical pathways. Genes & Development. PMID 33184218 DOI: 10.1101/gad.342956.120 |
0.716 |
|
| 2017 |
Molotkov A, Mazot P, Brewer JR, Cinalli RM, Soriano P. Distinct Requirements for FGFR1 and FGFR2 in Primitive Endoderm Development and Exit from Pluripotency. Developmental Cell. PMID 28552557 DOI: 10.1016/J.Devcel.2017.05.004 |
0.758 |
|
| 2016 |
Brewer JR, Mazot P, Soriano P. Genetic insights into the mechanisms of Fgf signaling. Genes & Development. 30: 751-71. PMID 27036966 DOI: 10.1101/Gad.277137.115 |
0.814 |
|
| 2015 |
Brewer JR, Molotkov A, Mazot P, Hoch RV, Soriano P. Fgfr1 regulates development through the combinatorial use of signaling proteins Genes & Development. 29: 1863-1874. PMID 26341559 DOI: 10.1101/Gad.264994.115 |
0.796 |
|
| 2015 |
Vasudevan HN, Mazot P, He F, Soriano P. Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways. Elife. 4. PMID 25951516 DOI: 10.7554/Elife.07186 |
0.82 |
|
| 2015 |
Vasudevan HN, Mazot P, He F, Soriano P. Author response: Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways Elife. DOI: 10.7554/Elife.07186.020 |
0.777 |
|
| 2015 |
Vasudevan HN, Mazot P, He F, Soriano P. Receptor tyrosine kinases modulate distinct transcriptional programs by differential usage of intracellular pathways Elife. 4. DOI: 10.7554/eLife.07186 |
0.785 |
|
| 2013 |
Boutterin MC, Mazot P, Faure C, Doly S, Gervasi N, Tremblay ML, Vigny M. Control of ALK (wild type and mutated forms) phosphorylation: specific role of the phosphatase PTP1B. Cellular Signalling. 25: 1505-13. PMID 23499906 DOI: 10.1016/j.cellsig.2013.02.020 |
0.362 |
|
| 2013 |
Cazes A, Louis-Brennetot C, Mazot P, Dingli F, Lombard B, Boeva V, Daveau R, Cappo J, Combaret V, Schleiermacher G, Jouannet S, Ferrand S, Pierron G, Barillot E, Loew D, et al. Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma. Cancer Research. 73: 195-204. PMID 23139213 DOI: 10.1158/0008-5472.Can-12-1242 |
0.324 |
|
| 2012 |
Mazot P, Cazes A, Dingli F, Degoutin J, Irinopoulou T, Boutterin MC, Lombard B, Loew D, Hallberg B, Palmer RH, Delattre O, Janoueix-Lerosey I, Vigny M. Internalization and down-regulation of the ALK receptor in neuroblastoma cell lines upon monoclonal antibodies treatment. Plos One. 7: e33581. PMID 22479414 DOI: 10.1371/Journal.Pone.0033581 |
0.457 |
|
| 2011 |
Mazot P, Cazes A, Boutterin MC, Figueiredo A, Raynal V, Combaret V, Hallberg B, Palmer RH, Delattre O, Janoueix-Lerosey I, Vigny M. The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking. Oncogene. 30: 2017-25. PMID 21242967 DOI: 10.1038/Onc.2010.595 |
0.408 |
|
| 2010 |
Bennasroune A, Mazot P, Boutterin MC, Vigny M. Activation of the orphan receptor tyrosine kinase ALK by zinc. Biochemical and Biophysical Research Communications. 398: 702-6. PMID 20621063 DOI: 10.1016/j.bbrc.2010.07.004 |
0.309 |
|
| 2007 |
Mathivet T, Mazot P, Vigny M. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)? Cellular Signalling. 19: 2434-43. PMID 17904822 DOI: 10.1016/j.cellsig.2007.07.011 |
0.324 |
|
| Show low-probability matches. |